Compare Adaptive Biotechnologies Corp (ADPT) vs United States Brent Oil Fund LP (BNO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs United States Brent Oil Fund LP — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while United States Brent Oil Fund LP trades at $50.8. The key difference: Adaptive Biotechnologies Corp is trading nearer its 52-week high, United States Brent Oil Fund LP nearer its low. Which is the better fit depends on your goals.
| ADPT | BNO | |
|---|---|---|
Market Cap | $4.04B | — |
Sector | Health | Commodities - Energy |
52-Week High | $25.45 | $60.13 |
52-Week Low | $12.30 | $27.20 |
Enterprise Value | $4.10B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About United States Brent Oil Fund LP
BNO is a commodity ETF that tracks the daily price of Brent crude oil futures. It provides exposure to the international oil benchmark, which often trades at a premium to the U.S. WTI benchmark, and is primarily used for short-term trading due to roll costs.
Read more on BNO →
